Abstract:

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality globally. Despite advancements in therapeutic interventions, there is a continual need for novel treatments with improved efficacy and safety profiles. Abradine hydrochloride (HCL) has emerged as a potential candidate for the management of CVDs due to its unique pharmacological properties. This research article provides an overview of the development of Abradine HCL, including its pharmacological profile, mechanisms of action, preclinical and clinical studies, as well as future directions for research and clinical application.

Description:

Abradine HCL, Cardiovascular Diseases, Abradine hydrochloride, pharmacological profile